Skip to main content
a board room filled with furniture and a large window

CVS Health makes changes to board of directors

Tony White and David Dorman are retiring from the board, and Roger Farah has been named independent chair.

CVS Health announced several changes to its board.

The company disclosed that David Dorman, independent chair of the board, is retiring at the end of his current term, which is effective with the annual meeting of stockholders on May 11. 

"On behalf of the board, our leadership team and our 300,000 CVS Health colleagues, I want to thank Dave for his contributions to CVS Health," president and CEO Karen Lynch, said. "His vision has helped drive the growth of our company, and we have all benefitted from his guidance and insight as we have advanced our strategy to reshape the consumer healthcare experience."

[Read more: CVS Health's Michelle Peluso is tasked with integrating the healthcare experience around the consumer]

In addition to Dorman retiring, Tony White also is set to retire from the board as he has reached the mandatory retiring age. Lastly, Roger Farah has been selected to succeed Dorman as independent chair, the company said. 

"It has been a great honor to serve on the board and as chair of CVS Health. I am proud of everything that we have accomplished and the challenges we overcame in building the nation's leading health solutions company," Dorman said. "I could not be more excited about what the future holds for CVS Health. Finally, I would like to thank all my fellow directors and all of our CVS Health colleagues for their support and partnership during my time on the board and as chair." 

Dorman was appointed to the board of directors of CVS Health in March 2006 and has served as chair since May 2011.

[Read more: CVS Health announces steps to accelerate omnichannel health strategy]

"It has been a privilege to serve with Dave since I joined the board in 2018. Looking forward, I am excited to partner with Karen as she leads CVS Health through this transformative period," Farah said. "No other company is better positioned to both impact health care at scale and drive profitable growth while enhancing shareholder value."

White, who has been a director on the board since 2011, is set to depart at the end of his current term in May, the company said. 

"I have worked with Roger for nearly a decade and I look forward to working with him during what is truly an exciting time for CVS Health," Lynch said. "Roger's experience and expertise will help guide us as we continue to execute our strategy and become an even bigger part of our customers' everyday health."

[Read More: CVS Health’s Brenda Lord highlights consumer trends influencing the retail giant’s store-brand portfolio]

Following the retirements of Dorman and White, the size of the board will be reduced to 11 directors, the company said.

"Tony has been a highly valued member of the board and we thank him for all his contributions to CVS Health," Lynch said. "His deep level of health care and life sciences expertise was critical to me and the board as we navigated through the pandemic to lead the delivery of COVID-19 testing and vaccinations."

This ad will auto-close in 10 seconds